Literature DB >> 34938536

Mechanisms of gram-positive vancomycin resistance (Review).

Samy Selim1.   

Abstract

Vancomycin-resistant bacteria (VRB) are important consideration in medicine and public health as they can cause life-threatening infections that appear to be resistant to therapy and persist in the body after medication. A wide spectrum of antimicrobial resistance characteristics, as well as various environmental and animal settings underlie the evolution of the most prevalent the most prevalent van genes in the VRB genome, indicating significant gene flow. As illnesses caused by VRB have become increasingly complex, several previously effective therapeutic techniques have become ineffective, complicating clinical care further. The focus of this review is the mechanism of vancomycin resistance in Enterococci, Staphylococci and Lactobacilli.
Copyright © 2020, Spandidos Publications.

Entities:  

Keywords:  gram-positive bacteria; mechanisms; resistance; vancomycin

Year:  2021        PMID: 34938536      PMCID: PMC8686198          DOI: 10.3892/br.2021.1490

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  55 in total

1.  Activity of glycopeptides against vancomycin-resistant gram-positive bacteria.

Authors:  T I Nicas; C T Cole; D A Preston; A A Schabel; R Nagarajan
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

2.  Structural relationship between the vancomycin resistance protein VanH and 2-hydroxycarboxylic acid dehydrogenases.

Authors:  M Arthur; C Molinas; S Dutka-Malen; P Courvalin
Journal:  Gene       Date:  1991-07-15       Impact factor: 3.688

3.  Heterogeneous expression of glycopeptide resistance in enterococci associated with transfer of vanB.

Authors:  M K Hayden; R N Picken; D F Sahm
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

4.  Bacteremia caused by staphylococci with inducible vancomycin heteroresistance.

Authors:  S S Wong; P L Ho; P C Woo; K Y Yuen
Journal:  Clin Infect Dis       Date:  1999-10       Impact factor: 9.079

5.  Emergence of high-level resistance to glycopeptides in Enterococcus gallinarum and Enterococcus casseliflavus.

Authors:  S Dutka-Malen; B Blaimont; G Wauters; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

6.  Detection of vancomycin nonsusceptible strains in clinical isolates of Staphylococcus aureus in northern Iran.

Authors:  Leila Asadpour; Niloufar Ghazanfari
Journal:  Int Microbiol       Date:  2019-02-18       Impact factor: 2.479

7.  Clinical significance of tolerant strains of Staphylococcus aureus in patients with endocarditis.

Authors:  K R Rajashekaraiah; T Rice; V S Rao; D Marsh; B Ramakrishna; C A Kallick
Journal:  Ann Intern Med       Date:  1980-12       Impact factor: 25.391

Review 8.  Renaissance of vancomycin: approaches for breaking antibiotic resistance in multidrug-resistant bacteria.

Authors:  Eric Mühlberg; Florian Umstätter; Christian Kleist; Cornelius Domhan; Walter Mier; Philipp Uhl
Journal:  Can J Microbiol       Date:  2019-09-23       Impact factor: 2.419

9.  Emergence of teicoplanin-resistant coagulase-negative staphylococci.

Authors:  E Cercenado; M E García-Leoni; M D Díaz; C Sánchez-Carrillo; P Catalán; J C De Quirós; E Bouza
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

Review 10.  Molecular mechanisms of vancomycin resistance.

Authors:  Peter J Stogios; Alexei Savchenko
Journal:  Protein Sci       Date:  2020-01-23       Impact factor: 6.725

View more
  1 in total

1.  Effects of boric acid and potassium metaborate on cytokine levels and redox stress parameters in a wound model infected with methicillin‑resistant Staphylococcus aureus.

Authors:  Demet Celebi; Ali Taghizadehghalehjoughi; Sumeyye Baser; Sidika Genc; Aysegul Yilmaz; Yesim Yeni; Fatma Yesilyurt; Serkan Yildirim; Ismail Bolat; Saban Kordali; Ferah Yilmaz; Ahmet Hacimuftuoglu; Ozgur Celebi; Denisa Margina; George Mihai Nitulescu; Demetrios A Spandidos; Aristidis Tsatsakis
Journal:  Mol Med Rep       Date:  2022-08-03       Impact factor: 3.423

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.